Investors Buy Large Volume of Call Options on Aehr Test Systems (NASDAQ:AEHR)

Aehr Test Systems (NASDAQ:AEHR – Get Free Report) was the target of unusually large options trading on Tuesday. Stock traders acquired 14,866 call options on the company. This represents an increase of approximately 51% compared to the typical daily volume of 9,837 call options.

Insiders Place Their Bets

In related news, Director Howard T. Slayen sold 5,700 shares of the stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $133.03, for a total transaction of $758,271.00. Following the transaction, the director directly owned 140,667 shares in the company, valued at approximately $18,712,931.01. This represents a 3.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Rhea J. Posedel sold 5,973 shares of the stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $140.00, for a total transaction of $836,220.00. Following the transaction, the director owned 381,989 shares in the company, valued at approximately $53,478,460. The trade was a 1.54% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 87,475 shares of company stock worth $11,459,240. 4.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Aehr Test Systems

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Pictet Asset Management Holding SA raised its position in Aehr Test Systems by 48.7% during the third quarter. Pictet Asset Management Holding SA now owns 24,769 shares of the semiconductor company’s stock valued at $2,467,000 after acquiring an additional 8,115 shares in the last quarter. International Assets Investment Management LLC bought a new stake in shares of Aehr Test Systems during the 3rd quarter worth about $203,000. Commonwealth Equity Services LLC acquired a new position in shares of Aehr Test Systems during the 3rd quarter valued at about $746,000. IPG Investment Advisors LLC bought a new position in shares of Aehr Test Systems in the 3rd quarter valued at approximately $214,000. Finally, Signature Equity Partners LLC acquired a new stake in Aehr Test Systems in the 3rd quarter worth approximately $102,000. Institutional investors own 69.69% of the company’s stock.

Aehr Test Systems Trading Up 24.9%

AEHR traded up $12.83 during trading hours on Tuesday, hitting $64.30. The company’s stock had a trading volume of 6,484,428 shares, compared to its average volume of 2,503,422. The company has a 50-day simple moving average of $82.66 and a 200 day simple moving average of $73.90. The firm has a market capitalization of $2.10 billion, a PE ratio of -266.64 and a beta of 3.47. Aehr Test Systems has a fifty-two week low of $18.70 and a fifty-two week high of $147.40.

Aehr Test Systems (NASDAQ:AEHR – Get Free Report) last issued its quarterly earnings results on Monday, November 2nd. The semiconductor company reported $0.28 EPS for the quarter, beating analysts’ consensus estimates of $0.11 by $0.17. The company had revenue of $33.01 million for the quarter, compared to analyst estimates of $27.53 million. Aehr Test Systems had a negative return on equity of 3.83% and a negative net margin of 14.25%. Research analysts expect that Aehr Test Systems will post 0.45 earnings per share for the current fiscal year.

Key Headlines Impacting Aehr Test Systems

Here are the key news stories impacting Aehr Test Systems this week:

  • Positive Sentiment: Quarterly results exceeded expectations. Fiscal Q1 2027 revenue reached a record $33.0 million, above the $27.5 million analyst consensus, while earnings per share of $0.28 more than doubled the $0.11 estimate. AEHR Q1 Earnings Beat Estimates on AI Demand, Revenue Outlook Raised
  • Positive Sentiment: Full-year guidance was raised well above Wall Street expectations. Management now expects fiscal 2027 revenue of $150 million, compared with consensus of approximately $138.4 million, and described the outlook as roughly triple fiscal 2026 revenue. Aehr Test Systems Reports Record First Quarter Revenue and Raises Outlook
  • Positive Sentiment: AI-related demand and visibility improved. Aehr cited increasing orders from AI semiconductor customers, stronger margins and an effective backlog of $109.3 million as of November 1. Management is also targeting at least a 20% non-GAAP net income margin, suggesting potential operating leverage as sales scale. Aehr Test Systems: 3 Key Takeaways for Long-Term Investors
  • Neutral Sentiment: Profitability remains a consideration. Although adjusted quarterly earnings beat estimates, the company still reported a negative net margin and negative return on equity, leaving execution, customer concentration and conversion of the backlog into revenue as key risks.

Wall Street Analyst Weigh In

Several analysts have issued reports on AEHR shares. Wall Street Zen raised shares of Aehr Test Systems from a “sell” rating to a “hold” rating in a research report on Saturday, July 18th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aehr Test Systems in a research report on Tuesday, October 27th. Craig Hallum restated a “buy” rating and issued a $125.00 target price on shares of Aehr Test Systems in a research note on Wednesday, July 15th. Lake Street Capital reiterated a “buy” rating and set a $110.00 price target on shares of Aehr Test Systems in a research report on Wednesday, July 15th. Finally, Zacks Research cut Aehr Test Systems from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 14th. One analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $132.50.

Read Our Latest Analysis on Aehr Test Systems

About Aehr Test Systems

(Get Free Report)

Aehr Test Systems (NASDAQ: AEHR) develops and manufactures test and burn-in equipment used to qualify and screen semiconductor devices. Its systems are designed to identify manufacturing defects and reliability issues before chips are shipped to customers, helping semiconductor manufacturers improve production yields and product quality.

The company’s product portfolio includes the FOX family of semiconductor test systems, including the FOX-XP, FOX-NP and FOX-1P platforms. Aehr also provides wafer contactors, DiePak carriers and related test fixtures and software.

See Also

Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.